Fierce Pharma Biopharma News & Insights
5 days ago · Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance.
Top 10 most anticipated drug launches of 2024 | Fierce Pharma
Jan 29, 2024 · Every year, we tap Evaluate's annual preview report to assess the biggest potential new drugs of the year ahead. Typically, major pharmaceutical and biotechnology companies are featured, each ...
Pharma | Fierce Pharma
Oct 14, 2024 · The company had initially hoped to launch its T-cell lymphoma treatment Lymphir within five months of the August FDA nod.
Top 20 pharma companies by 2023 revenue - Fierce Pharma
There were changes at the top and the bottom of last year’s top 20 pharma rankings by revenue. And, in between, Novo Nordisk made a significant leap, jumping five spots propelled by skyrocketing ...
The top 15 blockbuster patent expirations coming this decade
Looking out over the next decade, some of the biggest drugs in the industry will tumble off the patent cliff, putting pharma giants in the hot seat as investors clamor for their next blockbuster.
The top 10 vaccine companies worldwide - Fierce Pharma
What a difference five years—and a global pandemic—can make in reshaping an industry. When Fierce Pharma last published our rankings of the top vaccine players back in 2017, we highlighted the ...
Trump won a second term. What does it mean for biopharma?
Nov 6, 2024 · On Tuesday night, millions of Americans watched as former president Donald J. Trump gathered up enough electoral votes needed to win the U.S. | Over his first term, Donald Trump advocated for ...
UPDATED: FDA lists all doses of Novo's Wegovy as available, …
Oct 31, 2024 · Elsewhere, Novo Holdings, which acts as a holding company for the drugmaker, revealed plans to purchase contract manufacturing giant Catalent for $16.5 billion in early February. As part of the ...
The top 20 drugs by worldwide sales in 2023 | Fierce Pharma
May 28, 2024 · It's been several years since COVID-19 vaccines from Pfizer and Moderna jumped to the top of the pharma industry's sales charts, displacing longtime stalwarts with unprecedented sales. But, as ...
In long-awaited deal, Sun finally buys out Taro for $348M - Fierce …
Jan 18, 2024 · In its most recent financial report, Taro posted revenue of $593 million for the 12 months ending on Sept. 30, 2023, for a 4% increase year over year. Taro’s annual revenue has generally been in ...